MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from revenue
interest financing...
-$150,000K
Proceeds from
borrowings, net of issuance...
$60,102K
Proceeds from sale of
marketable securities
$462,290K
Proceeds from exercises
of options
$10,111K
Proceeds from issuance of
common stock under espp
-$1,310K
Net cash provided by
financing activities
$202,535K
Net cash provided by
investing activities
$99,520K
Canceled cashflow
$18,988K
Canceled cashflow
$362,770K
Net decrease in cash
and cash...
$128,363K
Canceled cashflow
$173,692K
Payments on borrowings
$11,899K
Payments on debt issuance
costs
$6,596K
Payments on finance
agreement
$493K
Stock-based compensation
$35,894K
Accrued expenses
$12,350K
Non-cash interest on
revenue interest...
-$10,138K
Accounts payable
$3,131K
Depreciation and
amortization
$1,739K
Change in fair value of
warrant liability
$812K
Amortization of issuance
costs
$662K
Interest receivable on
marketable securities
-$285K
Non-cash lease expense
$275K
Net loss on disposal
of property and...
-$33K
Purchases of marketable
securities
$354,416K
Cash paid for
capitalized market approval...
$8,000K
Purchases of property and
equipment
$354K
Net cash used in
operating activities
-$173,427K
Effect of foreign
exchange rate changes on...
-$265K
Canceled cashflow
$65,319K
Net loss
-$204,627K
Inventory
$11,411K
Contract liabilities
$7,869K
Amortization of premium and
discounts on marketable...
$5,284K
Prepaid expenses and
other current assets
$4,265K
Accounts receivable
$3,354K
Unrealized foreign
currency transaction...
$1,085K
Other non-current
assets
$846K
Realized loss (gain) on
marketable securities
$5K
Back
Back
Cash Flow
source: myfinsight.com
Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. (NUVB)